Excess mortality with salmeterol as single-agent therapy

No authors listed

Comparative Study

No authors listed. Prescrire Int. 2003 Aug.

. 2003 Aug;12(66):142.

No abstract available

Similar articles

Comments on the Salmeterol Multicenter Asthma Research Trial.
Seymour SM, Sullivan EJ, Chowdhury BA, Meyer RJ, Davi RC. Seymour SM, et al. Chest. 2006 Sep;130(3):930-1; author reply 931. doi: 10.1378/chest.130.3.930. Chest. 2006. PMID: 16963702 No abstract available.
Asthma: fatal exacerbations with long-acting beta2 agonist therapy without concomitant steroid therapy.
[No authors listed] [No authors listed] Prescrire Int. 2007 Apr;16(88):69-70. Prescrire Int. 2007. PMID: 17458051
Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
Friedman HS, Eid NS, Crespi S, Wilcox TK, Reardon G. Friedman HS, et al. Clin Ther. 2009 May;31(5):1056-63. doi: 10.1016/j.clinthera.2009.05.008. Clin Ther. 2009. PMID: 19539106
[Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S, Vogelmeier C, Buhl R. Korn S, et al. Med Klin (Munich). 2008 May 15;103(5):299-310. doi: 10.1007/s00063-008-1050-y. Med Klin (Munich). 2008. PMID: 18484216 Review. German.
Combination therapy with the single inhaler salmeterol/fluticasone propionate versus increased doses of inhaled corticosteroids in patients with asthma.
Li HT, Zhang TT, Zhou H, Qu XJ, Wu WM, Huang J. Li HT, et al. Respiration. 2007;74(1):33-43. doi: 10.1159/000096023. Epub 2006 Sep 27. Respiration. 2007. PMID: 17008769 Review.

Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.
Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ. Ducharme FM, et al. Cochrane Database Syst Rev. 2010 Apr 14;2010(4):CD005533. doi: 10.1002/14651858.CD005533.pub2. Cochrane Database Syst Rev. 2010. PMID: 20393943 Free PMC article.
Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children.
Ni Chroinin M, Greenstone I, Lasserson TJ, Ducharme FM. Ni Chroinin M, et al. Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD005307. doi: 10.1002/14651858.CD005307.pub2. Cochrane Database Syst Rev. 2009. PMID: 19821344 Free PMC article.